These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23240370)

  • 1. The variable natural history of idiopathic dilated cardiomyopathy.
    Parakh K; Kittleson MM; Heidecker B; Wittstein IS; Judge DP; Champion HC; Barouch LA; Baughman KL; Russell SD; Kasper EK; Sitammagari KK; Hare JM
    Isr Med Assoc J; 2012 Nov; 14(11):666-71. PubMed ID: 23240370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of right ventricular function and interstitial fibrosis in idiopathic dilated cardiomyopathy: hemodynamic correlates and prognostic value.
    La Vecchia L; Bedogni F; Castellani A; Martini M; Paccanaro M; Sartori M; Bozzola L; Bevilacqua P; Vincenzi M
    G Ital Cardiol; 1998 May; 28(5):513-23. PubMed ID: 9646066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)].
    Gavazzi A; De Maria R; Porcu M; Beretta L; Casazza F; Castelli G; Luvini M; Parodi O; Recalcati F; Renosto G
    G Ital Cardiol; 1995 Sep; 25(9):1109-25. PubMed ID: 8529848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?".
    Zecchin M; Merlo M; Pivetta A; Barbati G; Lutman C; Gregori D; Serdoz LV; Bardari S; Magnani S; Di Lenarda A; Proclemer A; Sinagra G
    Am J Cardiol; 2012 Mar; 109(5):729-35. PubMed ID: 22176998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy.
    Christ M; Klima T; Grimm W; Mueller HH; Maisch B
    Eur Heart J; 2006 Mar; 27(6):691-9. PubMed ID: 15821011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15185463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome factors of idiopathic dilated cardiomyopathy in children - a long-term follow-up review.
    Azevedo VM; Santos MA; Albanesi Filho FM; Castier MB; Tura BR; Amino JG
    Cardiol Young; 2007 Apr; 17(2):175-84. PubMed ID: 17244382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
    Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G;
    Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15346692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases].
    Sinagra G; Maras P; D'Ambrosio A; Gregori D; Bussani R; Silvestri F; Morgera T; Pinamonti B; Salvi A; Alberti E; Di Lenarda A; Lardieri G; Klugmann S; Camerini F
    G Ital Cardiol; 1997 Aug; 27(8):758-74. PubMed ID: 9312504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pacing-induced mechanical alternans in patients with mild-to-moderate idiopathic dilated cardiomyopathy in sinus rhythm.
    Hirashiki A; Izawa H; Somura F; Obata K; Kato T; Nishizawa T; Yamada A; Asano H; Ohshima S; Noda A; Iino S; Nagata K; Okumura K; Murohara T; Yokota M
    J Am Coll Cardiol; 2006 Apr; 47(7):1382-9. PubMed ID: 16580526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.
    Ng AC; Sindone AP; Wong HS; Freedman SB
    Int J Cardiol; 2008 Sep; 129(2):198-204. PubMed ID: 17706807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-term results of heart transplantation, cardiomyoplasty, and medical treatment of refractory heart failure caused by idiopathic dilated cardiomyopathy.
    Bocchi EA; Bellotti G; Moreira LF; Bacal F; de Moraes AV; Fiorelli A; Mansur A; Stolf N; Jatene A; Pileggi F
    J Heart Lung Transplant; 1996 Jul; 15(7):736-45. PubMed ID: 8820791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.
    Herrmann S; Schmidt-Petersen K; Pfeifer J; Perrot A; Bit-Avragim N; Eichhorn C; Dietz R; Kreutz R; Paul M; Osterziel KJ
    Eur Heart J; 2001 Oct; 22(20):1948-53. PubMed ID: 11601839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitral valve surgery for mitral regurgitation in patients with advanced dilated cardiomyopathy.
    Gatti G; Cardu G; Pugliese P
    Ital Heart J; 2003 Jan; 4(1):29-34. PubMed ID: 12690918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years.
    Merlo M; Pivetta A; Pinamonti B; Stolfo D; Zecchin M; Barbati G; Di Lenarda A; Sinagra G
    Eur J Heart Fail; 2014 Mar; 16(3):317-24. PubMed ID: 24464640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dobutamine-induced mechanical alternans is a marker of poor prognosis in idiopathic dilated cardiomyopathy.
    Hirashiki A; Izawa H; Cheng XW; Unno K; Ohshima S; Murohara T
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1004-9. PubMed ID: 20626415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.